MENU
+Compare
ABBV
Stock ticker: NYSE
AS OF
Aug 19 closing price
Price
$206.19
Change
-$0.38 (-0.18%)
Capitalization
364.25B

ABBV ABBVIE Forecast, Technical & Fundamental Analysis

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABBV with price predictions
Aug 19, 2025

ABBV in upward trend: price rose above 50-day moving average on July 22, 2025

ABBV moved above its 50-day moving average on July 22, 2025 date and that indicates a change from a downward trend to an upward trend. In of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 01, 2025. You may want to consider a long position or call options on ABBV as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABBV just turned positive on August 01, 2025. Looking at past instances where ABBV's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in of 362 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 356 cases where ABBV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABBV broke above its upper Bollinger Band on August 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. ABBV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (243.902) is very high in comparison to the industry average of (9.492). ABBV's P/E Ratio (98.186) is considerably higher than the industry average of (23.868). Projected Growth (PEG Ratio) (0.435) is also within normal values, averaging (1.900). Dividend Yield (0.031) settles around the average of (0.027) among similar stocks. ABBV's P/S Ratio (6.266) is slightly higher than the industry average of (3.417).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABBV is expected to report earnings to rise 9.76% to $3.26 per share on October 24

ABBVIE ABBV Stock Earnings Reports
Q3'25
Est.
$3.26
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.08
The last earnings report on July 31 showed earnings per share of $2.97, beating the estimate of $2.96. With 3.98M shares outstanding, the current market capitalization sits at 364.25B.
A.I.Advisor
published Dividends

ABBV paid dividends on August 15, 2025

ABBVIE ABBV Stock Dividends
А dividend of $1.64 per share was paid with a record date of August 15, 2025, and an ex-dividend date of July 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XLE85.080.03
+0.04%
The Energy Select Sector SPDR® ETF
GHTA31.27N/A
N/A
Goose Hollow Tactical Allocation ETF
DFSI40.48N/A
N/A
Dimensional International Sstby Cr 1 ETF
PATN24.55N/A
N/A
PACER FDS TR
AMDY8.52-0.46
-5.12%
YieldMax AMD Option Income Strategy ETF

ABBV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with AMGN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-0.18%
AMGN - ABBV
54%
Loosely correlated
+1.00%
PFE - ABBV
54%
Loosely correlated
+1.00%
BIIB - ABBV
45%
Loosely correlated
+2.17%
NVS - ABBV
43%
Loosely correlated
+0.76%
JNJ - ABBV
43%
Loosely correlated
+0.88%
More